Tetrachlorodecaoxide

"Tetrachlorodecaoxide" (TCDO) is a chlorite-containing substance with claimed immunomodulatory, macrophage-activating properties.^[1] WF10 (Macrokine, Immunokine, Oxoferin) is an aqueous solution of tetrachlorodecaoxide designed for intravenous injection.^[2] Tetrachlorodecaoxide/WF10 were originally developed by Oxo Chemie.^[3] The chemical formula is given as Cl₄H₂O₁₁^4-.^[4][2] This incomplete formula shows a mixture of chlorite ion, water, and molecular oxygen: "Cl₄H₂O₁₁^4-" = 4ClO₂⁻ + H₂O + O₂. Oxoferin was found to be equivalent with aqueous sodium chlorite.^[5]

Tetrachlorodecaoxide

Clinical data
ATC code	D03AX11 (WHO)
Identifiers
IUPAC name Molecular oxygen tetrachlorite hydrate
CAS Number	92047-76-2 Y
PubChem CID	3000391
UNII	549BT7IE1Q
CompTox Dashboard (EPA)	DTXSID40238840
ECHA InfoCard	100.101.959
(verify)

Tetrachlorodecaoxide / WF10 is used in the management of radiation cystitis,^[6] is effective in the treatment of diabetic foot ulcers,^[7] and is used in wound healing, where the mechanism of action is activation of the macrophage system, and increasing the partial pressure of oxygen in the wound.^[8]